Clinical Trial Update: The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs

View source ↗

Summary

A clinical trial update examining the relationship between ripretinib exposure and its efficacy and safety in patients with advanced gastrointestinal stromal tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• QINLOCK (ripretinib)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Gastrointestinal Stromal Tumors | Status: RECRUITING